Weight-Loss Drugs Linked to Scurvy Resurgence as Malnutrition Risks Soar
The revolutionary advent of weight-loss medications such as Ozempic and Mounjaro has undeniably transformed the global battle against obesity. However, a stark new warning has emerged from medical researchers: these drugs are triggering a concerning resurgence of scurvy, an ancient disease once relegated to the history books and pirate lore.
Alarming Research Findings on Dietary Neglect
In a comprehensive review of 41 studies involving over 50,000 participants, Australian researchers uncovered a critical oversight. While all trials meticulously monitored weight loss, only two tracked participants' diets for nutritional deficiencies. Dr Clare Collins, a leading nutrition and dietetics researcher who spearheaded the paper published in the BMJ, emphasized the gravity of this gap.
'These medications work, there's no question about that,' Dr Collins stated. 'But a reduction in body weight does not automatically mean the person is well nourished or healthy. Nutrition plays a critical role in health, and right now, it's largely missing from the evidence.'
The Return of a Historic Disease
Scurvy, caused by a severe vitamin C deficiency, was once rampant among 17th and 18th-century sailors deprived of fresh fruits and vegetables, claiming an estimated two million lives in Britain alone. Today, doctors in the United States are reporting a rise in cases linked to weight-loss drug use. The disease manifests with swollen, purple, and bleeding gums, and can progress to symptoms like bleeding under the skin, easy bruising, leg swelling, and dry, brittle hair that coils like a corkscrew.
Officials estimate at least seven percent of Americans are already deficient in vitamin C, and experts fear weight-loss drugs could accelerate this trend. Scurvy typically develops within one to three months of a deficiency, according to the Cleveland Clinic. While treatable with vitamin C supplements and dietary changes, serious cases can lead to permanent gum damage and tooth loss.
How Weight-Loss Drugs Increase Risk
These medications heighten the risk of scurvy by virtually eliminating appetite, causing users to eat less and increasing the likelihood of nutrient deficiencies. Side effects such as nausea, vomiting, and constipation further deter food consumption. Many patients take the drugs for months or even years, raising the risk of chronic malnutrition that can precipitate diseases like scurvy.
Dr Collins revealed that during her research, she was contacted by doctors documenting scurvy in patients on weight-loss drugs. 'Let’s not wait for every doctor to see a case of scurvy,' she urged. 'Let’s get on the front foot and link these chronic management plans to a dietitian referral.'
Celebrity Cases and Broader Concerns
Rock singer Robbie Williams, 51, was diagnosed with scurvy after taking an appetite-suppressant described as 'similar to Ozempic.' He lost 28 pounds, dropping from 195 to 169 pounds, and reported feeling sad, depressed, and exhausted due to nutrient deprivation.
Former Olympic athlete and celebrity personal trainer Sarah Lindsay, whose clients include Piers Morgan and Ellie Goulding, has also raised alarms. 'The level of abuse now is rife, thin people wanting to become even thinner,' she told The Sun. 'My worry is the long-term effects of being malnourished... or even a comeback of a deficiency disease like scurvy.'
Beyond Scurvy: Other Nutritional Deficiencies
The concerns extend beyond vitamin C. Researchers have linked weight-loss drugs to deficiencies in thiamine, a nutrient from pork, fish, and legumes that supports nerve function, potentially leading to neurological and heart complications. Protein deficiencies are also reported, causing patients to lose more muscle than fat.
Dr Collins warned that without robust dietary data, researchers cannot fully understand the broader effects of drugs like Ozempic and Wegovy. 'For such an expense, it is a marked miss,' she noted, highlighting the need for comprehensive monitoring in future trials.
Patients are advised to follow a high-protein, balanced diet and engage in weight training to minimize muscle loss while on these medications, though many fail to adhere to this guidance. As the use of weight-loss drugs expands, the call for integrated nutritional support grows louder to prevent a full-blown public health crisis.
